Treating midlife high blood pressure to a systolic target of 120 mmHg reduced the risk of mild cognitive impairment by 19 percent in the SPRINT-MIND randomized trial. That result, published in JAMA in 2019, is the strongest randomized evidence we have that any intervention can slow the onset of cognitive impairment in adults at risk. The Lancet Commission's 2024 dementia framework lists hypertension as one of fourteen modifiable risk factors, and intensive control is one of the more replicable findings in the lifestyle-and-dementia literature.

The case for paying attention to blood pressure is not subtle. Hypertension damages the small vessels that feed the brain. That damage accumulates silently for decades. By the time it shows up on a cognitive test, much of the harm has already been done. The good news is that the damage is preventable, the medications are cheap, and the lifestyle moves that lower blood pressure are the same ones that help the rest of the body.

The short answer: If you are over 40 and have hypertension, treating it to a systolic target of 120 to 130 mmHg is one of the highest-leverage things you can do for your long-term cognition. The evidence is randomized and clinically meaningful.

What did SPRINT-MIND actually measure?

The SPRINT trial was a large NIH-funded cardiovascular study that randomized 9,361 adults aged 50 and older with hypertension and elevated cardiovascular risk to one of two blood-pressure targets. The intensive group aimed for systolic below 120 mmHg. The standard group aimed for below 140 mmHg, the older guideline target. SPRINT-MIND was the pre-specified cognitive sub-study, with primary outcome of probable dementia and secondary outcomes including mild cognitive impairment (MCI) and a composite of MCI plus dementia.

After a median 3.3 years of treatment and roughly 5 years of follow-up, the intensive group had:

The probable-dementia primary outcome falling short of significance is the part the trial gets criticized for. The trial was stopped early for cardiovascular benefit (intensive control reduced cardiovascular events and overall mortality by 27 percent), which truncated dementia accrual; dementia takes longer than MCI to develop, and the shortened follow-up under-powered that endpoint. The MCI signal, which the trial was statistically powered to detect, came in clearly.

Why does blood pressure damage the brain?

The mechanism is small-vessel disease. The brain depends on a dense network of tiny arterioles that adjust pressure to maintain steady perfusion. Chronic hypertension thickens and stiffens those vessels. They become less responsive to local oxygen demand, more prone to leakage, and more likely to occlude. Over decades, this produces the white-matter hyperintensities, microbleeds, and lacunar infarcts that show up on the MRI scans of people with long-standing hypertension.

The cumulative effect is what neurologists call vascular contributions to cognitive impairment and dementia (VCID). It often co-exists with Alzheimer's pathology, and the two appear to interact: vascular damage lowers the threshold at which Alzheimer's-type lesions produce clinical symptoms. This is part of why cognitive reserve matters; the brain that has been kept vascularly healthy can absorb more pathology before symptoms appear.

The Iadecola et al., 2016, AHA scientific statement is the cleanest synthesis of the mechanistic evidence. It walks through how chronic hypertension affects the blood-brain barrier, glymphatic clearance (the brain's waste-removal system, which operates mostly during deep sleep), and the regulation of cerebral blood flow.

"Hypertension is among the most consistently identified midlife risk factors for late-life cognitive impairment and dementia."

Iadecola et al., 2016, Hypertension (AHA scientific statement)

What target is right?

The trial used 120 mmHg systolic, but the population it studied was specifically adults over 50 with hypertension and elevated cardiovascular risk. The 2024 Lancet Commission recommends treating hypertension actively from midlife to a target below 130 mmHg as a population-level dementia-prevention strategy. The 2017 ACC/AHA hypertension guideline uses 130/80 mmHg as the threshold for diagnosis and treatment in most adults.

In practice, the right number depends on age, frailty, kidney function, and how easily you tolerate the medications. Several specifics worth knowing:

  1. Start measuring at home. Office readings overestimate true blood pressure by roughly 5 mmHg in many adults due to white-coat effect. Twice-daily home readings over a week give a more reliable baseline.
  2. Lifestyle goes first for mild elevation. Exercise, weight loss, reduced sodium, and a Mediterranean or DASH-style diet collectively lower systolic pressure by 10 to 20 mmHg in many people. That can take you out of the hypertensive range.
  3. The medications work. ACE inhibitors, ARBs, calcium-channel blockers, and thiazides are all first-line, all cheap, all generic. The 2020 Hughes meta-analysis in JAMA found that blood pressure lowering of any kind was associated with reduced incidence of dementia or cognitive impairment.
  4. Below 120 mmHg is harder to tolerate. Falls, kidney issues, and electrolyte disturbances are more common at the intensive target. The right number is the lowest one you can tolerate without side effects.
  5. Midlife is the window. The Lancet Commission focuses on hypertension between 40 and 65 because that is when the small-vessel damage accumulates. Late-life hypertension has a more complex relationship with cognition.

What about late-life and "the J-curve"?

A point that gets mentioned less often in popular coverage. In adults over 75, especially in those with frailty, very low blood pressure is associated with worse cognitive outcomes in some observational studies. This may reflect reverse causation (people with declining health have lower blood pressure) or it may be real (under-perfusion of an aging brain). The implication is not that hypertension is fine in the 80s. It is that the right target shifts with age and frailty, and that the evidence base for aggressive lowering is strongest in midlife.

What this means for you

If you are between 40 and 65, knowing your blood pressure is one of the highest-leverage things you can do for your long-term cognition. Get a validated home cuff. Take measurements twice a day for a week. If your average is above 130/80 mmHg, talk to your doctor about lifestyle changes and, if needed, medication. Combine that with the rest of the Lancet Commission's modifiable factors, and the cumulative effect on long-term risk is substantial.

Five minutes of focused memory training is a piece of brain-healthy living. Knowing your blood pressure number, and treating it if it is high, is a load-bearing piece. For how this fits into the rest of cognitive aging, see our brain health guide.